<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Types of intraocular lenses for cataract surgery in eyes with uveitis - Leung, TG - 2014 | Cochrane Library</title> <meta content="Types of intraocular lenses for cataract surgery in eyes with uveitis - Leung, TG - 2014 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007284.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Types of intraocular lenses for cataract surgery in eyes with uveitis - Leung, TG - 2014 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007284.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007284.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Types of intraocular lenses for cataract surgery in eyes with uveitis" name="citation_title"/> <meta content="Theresa G Leung" name="citation_author"/> <meta content="Johns Hopkins University School of Medicine" name="citation_author_institution"/> <meta content="Kristina Lindsley" name="citation_author"/> <meta content="Johns Hopkins Bloomberg School of Public Health" name="citation_author_institution"/> <meta content="klindsle@jhsph.edu" name="citation_author_email"/> <meta content="Irene C Kuo" name="citation_author"/> <meta content="Wilmer Eye Institute, Johns Hopkins University School of Medicine" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD007284.pub2" name="citation_doi"/> <meta content="2014" name="citation_date"/> <meta content="2014/03/04" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007284.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007284.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007284.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Lenses, Intraocular [classification]; Cataract [etiology]; Cataract Extraction [*methods]; Randomized Controlled Trials as Topic; Uveitis [*complications]; Visual Acuity" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007284.pub2&amp;doi=10.1002/14651858.CD007284.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="Nio3SV1W";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007284\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007284\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","ko","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007284.pub2",title:"Types of intraocular lenses for cataract surgery in eyes with uveitis",firstPublishedDate:"Mar 4, 2014 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Eyes and Vision Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Nio3SV1W&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007284.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007284.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007284.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007284.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007284.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007284.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007284.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007284.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007284.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007284.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2199 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007284.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full#CD007284-abs-0006"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full#CD007284-sec-0123"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full#CD007284-sec-0036"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full#CD007284-sec-0041"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full#CD007284-sec-0042"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full#CD007284-sec-0065"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full#CD007284-sec-0117"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/appendices#CD007284-sec-0127"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2014 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Types of intraocular lenses for cataract surgery in eyes with uveitis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/information#CD007284-cr-0002">Theresa G Leung</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/information#CD007284-cr-0003"><i class="icon corresponding-author fa fa-envelope"></i>Kristina Lindsley</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007284.pub2/information#CD007284-cr-0004">Irene C Kuo</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/information/en#CD007284-sec-0137">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 04 March 2014 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007284.pub2">https://doi.org/10.1002/14651858.CD007284.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007284-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007284-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007284-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007284-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007284-abs-0004">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD007284-abs-0003">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD007284-abs-0002">繁體中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007284-abs-0001" lang="en"> <section id="CD007284-sec-0001"> <h3 class="title" id="CD007284-sec-0001">Background</h3> <p>Cataract formation often occurs in people with uveitis. It is unclear which intraocular lens (IOL) type is optimal for use in cataract surgery for eyes with uveitis. </p> </section> <section id="CD007284-sec-0002"> <h3 class="title" id="CD007284-sec-0002">Objectives</h3> <p>To summarize the effects of different IOLs on visual acuity, other visual outcomes, and quality of life in people with uveitis. </p> </section> <section id="CD007284-sec-0003"> <h3 class="title" id="CD007284-sec-0003">Search methods</h3> <p>We searched CENTRAL (which contains the Cochrane Eyes and Vision Group Trials Register) (<i>The Cochrane Library</i> 2013, Issue 7), Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to August 2013), EMBASE (January 1980 to August 2013), Latin American and Caribbean Literature on Health Sciences (LILACS) (January 1982 to August 2013), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>) and the WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 14 August 2013. We also performed forward and backward searching using the Science Citation Index and the reference lists of the included studies, respectively, in August 2013. </p> </section> <section id="CD007284-sec-0004"> <h3 class="title" id="CD007284-sec-0004">Selection criteria</h3> <p>We included randomized controlled trials (RCTs) comparing hydrophobic or hydrophilic acrylic, silicone, or poly(methyl methacrylate) (PMMA) IOLs with or without heparin‐surface modification (HSM), with each other, or with no treatment in adults with uveitis, for any indication, undergoing cataract surgery. </p> </section> <section id="CD007284-sec-0005"> <h3 class="title" id="CD007284-sec-0005">Data collection and analysis</h3> <p>We used standard methodological procedures expected by The Cochrane Collaboration. Two review authors screened the search results and for included studies, assessed the risk of bias and extracted data independently. We contacted study investigators for additional information. We did not perform a meta‐analysis due to variability in reporting and follow‐up intervals for the primary and secondary outcomes of interest. </p> </section> <section id="CD007284-sec-0006"> <h3 class="title" id="CD007284-sec-0006">Main results</h3> <p>We included four RCTs involving 216 participants (range of 2 to 140 participants with uveitic cataract per trial) and comparing up to four types of IOLs. The largest study was an international study with centers in Brazil, Egypt, Finland, France, Japan, the Netherlands, Slovak Republic, Spain, and the USA; two studies were conducted in Germany and one in Saudi Arabia. There was substantial heterogeneity with respect to the ages of participants and etiologies of uveitis within and across studies. The length of follow‐up among the studies ranged from 1 to 24 months after cataract surgery. The studies were at low risk of selection bias, but two of the four studies did not employ masking and only one study included all randomized participants in the final analyses. The funding source was disclosed by investigators of the largest study (professional society) and not reported by the other three. Due to heterogeneity in lens types evaluated and outcomes reported among the trials, we did not combine data in a meta‐analysis. </p> <p>In the largest study (140 participants), the study eye of each participant was randomized to receive one of four types of IOLs: hydrophobic acrylic, silicone, HSM PMMA, or unmodified PMMA. Proportions of participants with one or more Snellen lines of visual improvement were similar among the four treatment groups at one year' follow‐up: 45 of 48 (94%) in the hydrophobic acrylic IOL group, 39 of 44 (89%) in the silicone IOL group, 18 of 22 (82%) in the HSM PMMA IOL group, and 22 of 26 (85%) in the unmodified PMMA IOL group. When comparing hydrophobic acrylic IOLs with silicone IOLs, the risk ratio (RR) was 1.06 (95% confidence interval (CI) 0.93 to 1.20). At one year' follow‐up, fewer eyes randomized to hydrophobic acrylic IOLs developed posterior synechiae when compared with eyes receiving silicone IOLs (RR 0.18, 95% CI 0.04 to 0.79); the effects between these groups were less certain with respect to developing posterior capsule opacification (PCO) (RR 0.74, 95% CI 0.41 to 1.37), corneal edema (RR 0.49, 95% CI 0.22 to 1.12), cystoid macular edema (RR 0.10, 95% CI 0.01 to 1.84), or mild IOL decentration (RR 0.92, 95% CI 0.06 to 14.22). </p> <p>Two intra‐individual studies also compared HSM PMMA IOLs with unmodified PMMA IOLs at three or six months of follow‐up. These studies, including a combined total of 16 participants with uveitis, were insufficiently powered to detect differences in outcomes among eyes of people with uveitis randomized to receive HSM PMMA IOLs when compared with fellow eyes receiving unmodified PMMA IOLs. </p> <p>In the fourth study (60 participants), the study eye of each participant was randomized to receive a hydrophobic or hydrophilic acrylic IOL. At three months, there were no statistical or clinical differences between hydrophobic and hydrophilic acrylic IOL types in the proportions of participants with two or more Snellen lines of visual improvement (RR 1.03, 95% CI 0.87 to 1.22). There were similar rates in the development of PCO between hydrophobic or hydrophilic acrylic IOLs at six months' follow‐up (RR 1.00, 95% CI 0.80 to 1.25). The effect of the lenses on posterior synechiae was uncertain at six months' follow‐up (RR 0.50, 95% CI 0.05 to 5.22). </p> <p>None of the included studies reported quality of life outcomes.</p> </section> <section id="CD007284-sec-0007"> <h3 class="title" id="CD007284-sec-0007">Authors' conclusions</h3> <p>Based on the trials identified in this review, there is uncertainty as to which type of IOL provides the best visual and clinical outcomes in people with uveitis undergoing cataract surgery. The studies were small, not all lens materials were compared in all studies, and not all lens materials were available in all study sites. Evidence of a superior effect of hydrophobic acrylic lenses over silicone lenses, specifically for posterior synechiae outcomes comes from a single study at a high risk of performance and detection bias. However, due to small sample sizes and heterogeneity in outcome reporting, we found insufficient information to assess these and other types of IOL materials for cataract surgery for eyes with uveitis. </p> </section> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007284-abs-0006" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007284-abs-0006">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007284-abs-0010">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007284-abs-0012">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007284-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD007284-abs-0008">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD007284-abs-0007">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007284-abs-0006" lang="en"> <h3>Comparison of artificial lenses placed in eyes with uveitis during cataract surgery</h3> <p><b>Background</b> </p> <p>Cataract, a cloudy lens within the eye, is a major complication in people with uveitis (inflammation of the middle layer of the eye). Different types of artificial lenses (intraocular lenses, IOLs) are available to insert into the eye after removal of the cloudy natural lens during cataract surgery. The purpose of this review is to summarize the effects of different artificial lenses in adults with uveitis. </p> <p><b>Study characteristics</b> </p> <p>The review authors searched the medical literature up to August 2013 and identified four randomized controlled trials (clinical studies where people are randomly put into one of two or more treatment groups) containing 216 participants investigating different lens types. Lens materials studied were acrylic, silicone, heparin surface modified, and poly(methyl methacrylate). The trials included participants with different causes of uveitis, compared different lens types, and reported different outcomes. Due to these differences across trials, no meta‐analysis (pooling of trial data) was performed. The largest trial (140 participants) was funded by a professional society. The other three trials did not report their funding sources. </p> <p><b>Key results</b> </p> <p>There is very limited evidence on which to determine the effects of different types of lens materials for people with uveitis. The results from the largest trial provide only preliminary evidence that acrylic lenses may perform better than silicone lenses in terms of improving vision and reducing the chances of post‐surgical inflammation and complications. At this time, there is not enough data to conclude whether additional types of lenses are preferable to other types. </p> <p><b>Quality of the evidence</b> </p> <p>Because the trials included small numbers of participants in each of the four lens‐type groups, there is uncertainty in the results of the studies. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007284-sec-0123" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007284-sec-0123"></div> <h3 class="title" id="CD007284-sec-0124">Implications for practice</h3> <section id="CD007284-sec-0124"> <p>Cataract surgery with intraocular lens (IOL) implantation in people with quiescent inflammation for at least three months is no longer discouraged in people with uveitis. There is ethnic/geographic variation in the etiology of uveitis, but the limited results we have from the largest of the four studies suggest that the chance of improved visual outcome is higher and the risk of complication is lower when using hydrophobic acrylic rather than silicone lenses. </p> <p>There is insufficient evidence that there are any differences in outcome or safety between hydrophobic and hydrophilic acrylic lenses; other than the one trial we identified, comparisons have been in nonrandomized studies (<a href="./references#CD007284-bbs2-0005" title="Abela‐FormanekC , AmonM , SchauersbergerJ , KrugerA , NeppJ , SchildG . Results of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses in uveitic eyes with cataract: comparison to a control group. Journal of Cataract and Refractive Surgery2002;28(7):1141‐52. Abela‐FormanekC , AmonM , SchauersbergerJ , SchildG , KolodjaschnaJ , Barisani‐AsenbauerT , et al. Uveal and capsular biocompatibility of 2 foldable acrylic intraocular lenses in patients with uveitis or pseudoexfoliation syndrome: comparison to a control group. Journal of Cataract and Refractive Surgery2002;28(7):1160‐72. Abela‐FormanekC , AmonM , SchildG , SchauersbergerJ , KolodjaschnaJ , Barisani‐AsenbaumT , et al. Inflammation after implantation of hydrophilic acrylic, hydrophobic acrylic, or silicone intraocular lenses in eyes with cataract and uveitis: comparison to a control group. Journal of Cataract and Refractive Surgery2002;28(7):1153‐9. ">Abela‐Formanek 2002</a>). Two small studies in addition to <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> compared heparin‐surface modification (HSM) poly(methyl methacrylate) (PMMA) IOLs with unmodified PMMA IOLs and found no clear differences; however, due to the small number of study participants, these studies may not have had enough participants in order to detect a difference. Based on the trials identified in this review, there is uncertainty as to which type of IOL provides the best visual and clinical outcomes in people with uveitis undergoing cataract surgery. </p> </section> <h3 class="title" id="CD007284-sec-0125">Implications for research</h3> <section id="CD007284-sec-0125"> <p>A large multicenter, international study would help answer the clinical questions of which types of people with uveitis fare better with cataract extraction and IOL implantation and which type of IOL to implant. Such study would require adequate numbers of each type of uveitic entity, and adults could be randomized to type of IOL using uveitic entity as a stratification variable for randomization. Subgroup analysis could then be performed on each uveitic entity. The outcome measures should be standard across all centers: classification standard (i.e. international Uveitis Study Group classification), uncorrected and best‐corrected visual acuity (BCVA), anterior and posterior segment inflammation using the same grading system. Ideally, the postoperative observer would be masked to type of IOL when assessing visual acuity, inflammation, cystoid macular edema (CME), and posterior capsule opacification (PCO). </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007284-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007284-sec-0036"></div> <section id="CD007284-sec-0037"> <h3 class="title" id="CD007284-sec-0037">Description of the condition</h3> <p>Uveitis is a complex intraocular inflammatory disease of the middle part of the eye. A wide variety of causes exists for uveitis, including autoimmune processes and infectious agents (<a href="./references#CD007284-bbs2-0037" title="McCannelCA , HollandGN , HelmCJ , CornellPJ , WinstonJV , RimmerTG . Causes of uveitis in the general practice of ophthalmology. UCLA Community‐Based Uveitis Study Group. American Journal of Ophthalmology1996;121(1):35‐46. ">McCannel 1996</a>). Nevertheless, the majority of uveitis cases are not associated with systemic diseases (<a href="./references#CD007284-bbs2-0038" title="Muñoz‐FernándezS , Martín‐MolaE . Uveitis. Best Practice Research in Clinical Rheumatology2006;20(3):487‐505. ">Muñoz‐Fernández 2006</a>). </p> <p>About 1% of the US population has uveitis (<a href="./references#CD007284-bbs2-0032" title="GritzDC , WongIG . Incidence and prevalence of uveitis in Northern California: the Northern California epidemiology of uveitis study. Ophthalmology2004;111(3):491‐500. ">Gritz 2004</a>). This condition appears to increase with age, with the highest incidence rates seen in older people (<a href="./references#CD007284-bbs2-0032" title="GritzDC , WongIG . Incidence and prevalence of uveitis in Northern California: the Northern California epidemiology of uveitis study. Ophthalmology2004;111(3):491‐500. ">Gritz 2004</a>; <a href="./references#CD007284-bbs2-0040" title="ReevesSW , SloanFA , LeePP , JaffeGJ . Uveitis in the elderly: epidemiological data from the National Long‐term Care Survey Medicare Cohort. Ophthalmology2006;113(2):302‐7. ">Reeves 2006</a>). </p> <p>Uveitis significantly impacts people's lives. It is thought to be responsible for approximately 5% to 20% of legal blindness in developed countries (<a href="./references#CD007284-bbs2-0026" title="BodaghiB , CassouxN , WechslerB , HannoucheD , FardeauC , PapoT , et al. Chronic severe uveitis: aetiology and visual outcomes in 927 patients from a single centre. Medicine2001;80(4):263‐70. ">Bodaghi 2001</a>). Many people with uveitis may also experience blurred vision, sensitivity to light, eye pain, dark floating spots, and redness. </p> <p>One of the common complications of uveitis is cataract formation (<a href="./references#CD007284-bbs2-0039" title="OkhraviN , LightmanSL , TowlerHM . Assessment of visual outcome after cataract surgery in patients with uveitis. Ophthalmology1999;106(4):710‐22. ">Okhravi 1999</a>). While the incidence of cataract varies according to the type of uveitis, it is potentially as high as 50% (<a href="./references#CD007284-bbs2-0043" title="RojasB , ZafirakisP , FosterCS . Cataract surgery in patients with uveitis. Current Opinion in Ophthalmology1997;8(1):6‐12. ">Rojas 1997</a>). Unlike the general public, people with uveitis often develop cataract at an earlier stage in life. Prior intraocular inflammation and corticosteroid use are thought to be associated with cataract development in individuals with uveitis (<a href="./references#CD007284-bbs2-0024" title="AlióJL , ChipontE . Phacoemulsification in patients with uveitis. In: LuLW , FineIH editor(s). Phacoemulsification in Difficult and Challenging Cases. New York: Thieme, 1999:65‐74. ">Alió 1999</a>). </p> </section> <section id="CD007284-sec-0038"> <h3 class="title" id="CD007284-sec-0038">Description of the intervention</h3> <p>Intraocular lens (IOL) insertion for cataracts is one of the most commonly performed surgical procedures (<a href="./references#CD007284-bbs2-0046" title="WoodcockM , ShahS , SmithRJ . Recent advances in customising cataract surgery. BMJ2004;328(7431):92‐6. ">Woodcock 2004</a>). An IOL is an implant placed in the eye at the time the cataractous crystalline lens is removed. During the early 1980s, the vast majority of practicing ophthalmologists considered it poor judgment to place an IOL in uveitic eyes (<a href="./references#CD007284-bbs2-0036" title="LichterPR . Intraocular lenses in uveitis patients. Ophthalmology1989;96(3):279‐80. ">Lichter 1989</a>). It was reasoned that there was not enough experience with IOLs to know whether uveitic eyes would tolerate them over many years. As increasing numbers of implants have been performed, considerable relaxation of the contraindications occurred (<a href="./references#CD007284-bbs2-0036" title="LichterPR . Intraocular lenses in uveitis patients. Ophthalmology1989;96(3):279‐80. ">Lichter 1989</a>). </p> <p>Since the 1990s, a great deal of discussion has centered on the surgical correction of cataracts in people with uveitis including indications and timing of surgery, optimal surgical technique, and pre‐ and postoperative surgical treatment for cataract extraction (<a href="./references#CD007284-bbs2-0024" title="AlióJL , ChipontE . Phacoemulsification in patients with uveitis. In: LuLW , FineIH editor(s). Phacoemulsification in Difficult and Challenging Cases. New York: Thieme, 1999:65‐74. ">Alió 1999</a>; <a href="./references#CD007284-bbs2-0029" title="DunnJP . Cataract surgery in patients with uveitic cataract. Techniques in Ophthalmology2009;7(1):3‐7. ">Dunn 2009</a>; <a href="./references#CD007284-bbs2-0030" title="FosterRE , LowderCY , MeislerDM , ZakovZN . Extracapsular cataract extraction and posterior chamber intraocular lens implantation in uveitis patients. Ophthalmology1992;99(8):1234‐41. ">Foster 1992</a>; <a href="./references#CD007284-bbs2-0039" title="OkhraviN , LightmanSL , TowlerHM . Assessment of visual outcome after cataract surgery in patients with uveitis. Ophthalmology1999;106(4):710‐22. ">Okhravi 1999</a>; <a href="./references#CD007284-bbs2-0045" title="VanGelderRN , LevequeTK . Cataract surgery in the setting of uveitis. Current Opinion in Ophthalmology2009;20(1):42‐5. ">Van Gelder 2009</a>). In the early 2000s, phacoemulsification with in‐the‐bag IOL implantation emerged as a preferred surgical procedure for most people with uveitis with cataract (<a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>). The surgery is often performed under local anesthesia with the person in 'twilight sleep' (not fully awake or fully sedated). </p> </section> <section id="CD007284-sec-0039"> <h3 class="title" id="CD007284-sec-0039">How the intervention might work</h3> <p>Poly(methyl methacrylate) (PMMA), a rigid, transparent plastic as known as Plexiglas or Lucite, was the first material for IOLs (<a href="./references#CD007284-bbs2-0035" title="KangS , KimMJ , ParkSH , JooCK . Comparison of clinical results between heparin surface modified hydrophilic acrylic and hydrophobic acrylic intraocular lens. European Journal of Ophthalmology2008;18(3):377‐83. ">Kang 2008</a>). Use of PMMA for IOLs has become superseded by flexible (or foldable) materials. The use of a more flexible IOL has allowed for a smaller incision, avoidance of stitches, shorter surgical time, and speedier postoperative recovery. It is believed that utilization of a flexible IOL placed in the intact capsular bag results in less surgical trauma and surgically induced inflammation than alternative approaches (<a href="./references#CD007284-bbs2-0042" title="RojasB , FosterCS . Cataract surgery in patients with uveitis. Current Opinion in Ophthalmology1996;7(1):11‐6. ">Rojas 1996</a>). Current flexible materials include silicone and acrylic (<a href="./references#CD007284-bbs2-0025" title="BellucciR . An introduction to intraocular lenses: material, optics, haptics, design and aberration. In: GüellJL editor(s). Cataract. ESASO Course Series. Vol. 3, Basel: Karger, 2013:38‐55. ">Bellucci 2013</a>). </p> <p>IOL materials are further distinguished as being either hydrophobic (repels water) or hydrophilic (combines or attracts water) based on the angle a water drop makes on the materials surface (hydrophobic materials result in greater contact angles and hydrophilic materials have more acute contact angles with water). Whether a lens is hydrophobic or hydrophilic is thought to affect the biocompatibility of the IOL in the eye, especially in people with history of ocular inflammation such as uveitis. Because the lens is surrounded by aqueous humor in the eye, it has been suggested that hydrophilic materials could be more biocompatible than hydrophobic materials in eyes with uveitis (<a href="./references#CD007284-bbs2-0005" title="Abela‐FormanekC , AmonM , SchauersbergerJ , KrugerA , NeppJ , SchildG . Results of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses in uveitic eyes with cataract: comparison to a control group. Journal of Cataract and Refractive Surgery2002;28(7):1141‐52. Abela‐FormanekC , AmonM , SchauersbergerJ , SchildG , KolodjaschnaJ , Barisani‐AsenbauerT , et al. Uveal and capsular biocompatibility of 2 foldable acrylic intraocular lenses in patients with uveitis or pseudoexfoliation syndrome: comparison to a control group. Journal of Cataract and Refractive Surgery2002;28(7):1160‐72. Abela‐FormanekC , AmonM , SchildG , SchauersbergerJ , KolodjaschnaJ , Barisani‐AsenbaumT , et al. Inflammation after implantation of hydrophilic acrylic, hydrophobic acrylic, or silicone intraocular lenses in eyes with cataract and uveitis: comparison to a control group. Journal of Cataract and Refractive Surgery2002;28(7):1153‐9. ">Abela‐Formanek 2002</a>; <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>). In addition, hydrophilic IOLs have been postulated to reduce electrostatic forces and cellular adhesion, consequently preventing the attraction of inflammatory cells and adherence of fibroblasts to the surface of the IOL (<a href="./references#CD007284-bbs2-0035" title="KangS , KimMJ , ParkSH , JooCK . Comparison of clinical results between heparin surface modified hydrophilic acrylic and hydrophobic acrylic intraocular lens. European Journal of Ophthalmology2008;18(3):377‐83. ">Kang 2008</a>; <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a>). </p> <p>PMMA lOLs are inherently hydrophobic, but can be modified by adding heparin to the surface of the lens to become hydrophilic. Silicone IOLs are hydrophobic. Acrylic IOLs may be hydrophobic or hydrophilic depending on the compounds in the material. Hydrophilic acrylic materials also may be referred to as hydrogel IOLs. </p> </section> <section id="CD007284-sec-0040"> <h3 class="title" id="CD007284-sec-0040">Why it is important to do this review</h3> <p>The use of flexible IOLs has increased compared with the traditional PMMA lens, but it is still unclear which IOL material (PMMA, silicone, acrylic) is optimal for use in cataract surgery for eyes with uveitis, or whether approaches such as heparin‐surface modification (HSM) are beneficial (<a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>). This systematic review evaluated the safety and efficacy of various IOLs for the treatment of cataract in people with uveitis. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007284-sec-0041" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007284-sec-0041"></div> <p>To summarize the effects of different IOLs on visual acuity, other visual outcomes, and quality of life in people with uveitis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007284-sec-0042" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007284-sec-0042"></div> <section id="CD007284-sec-0043"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007284-sec-0044"> <h4 class="title">Types of studies</h4> <p>We followed the methods set forth in the published protocol for this review (<a href="./references#CD007284-bbs2-0047" title="SsemandaE , LindsleyK , ErvinAM , KempenJ . Comparison of intraocular lens types for cataract surgery in eyes with uveitis. Cochrane Database of Systematic Reviews2008, Issue 3. [DOI: 10.1002/14651858.CD007284] ">Ssemanda 2008</a>). We included randomized controlled trials (RCTs) with at least three months of follow‐up after cataract surgery. </p> </section> <section id="CD007284-sec-0045"> <h4 class="title">Types of participants</h4> <p>We included trials that enrolled adults (18 years and older) with cataract developing after uveitis for any indication. We included studies that did not report the age of participants and studies that included some participants less than 18 years of age. We included studies in which only a subset of participants were eligible (i.e. had uveitic cataract) when outcome data were reported separately for this subset. </p> </section> <section id="CD007284-sec-0046"> <h4 class="title">Types of interventions</h4> <p>We included trials comparing hydrophobic or hydrophilic acrylic, silicone, or PMMA IOLs with or without HSM with each other, or with treatment. </p> </section> <section id="CD007284-sec-0047"> <h4 class="title">Types of outcome measures</h4> <section id="CD007284-sec-0048"> <h5 class="title">Primary outcomes</h5> <p>We considered that treatment was administered to reverse visual impairment. Thus, the primary outcome was the proportion of participants whose best‐corrected visual acuity (BCVA) improved at least five letters on the Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity chart, or the equivalent changes on the Snellen chart or other scales at least three months postoperatively by lens type. </p> </section> <section id="CD007284-sec-0049"> <h5 class="title">Secondary outcomes</h5> <p>Secondary outcomes at least three months postoperatively included the:</p> <p> <ul id="CD007284-list-0001"> <li> <p>proportion of participants requiring additional interventions by lens type;</p> </li> <li> <p>proportion of participants with posterior capsule opacification (PCO) postoperatively by lens type; </p> </li> <li> <p>proportion of participants with posterior synechiae by lens type;</p> </li> <li> <p>proportion of participants with increased inflammation by lens type;</p> </li> <li> <p>proportion of participants with an improvement in quality of life as measured by a validated scale by lens type; </p> </li> <li> <p>proportion of participants with adverse events (e.g. corneal edema, cystoid macular edema (CME), mild IOL decentration) by lens type. </p> </li> </ul> </p> <p>We also considered longer times of outcome assessment when available (i.e. six months, 12 months, etc.). </p> <p>As a post‐hoc decision, we decided to include additional visual acuity measures we felt represented patient‐important outcomes: </p> <p> <ul id="CD007284-list-0002"> <li> <p>proportion of participants with BCVA 20/40 or better (Snellen equivalent): in the US, BCVA of 20/40 is the minimum visual acuity requirement for possessing a unrestricted driver's license; </p> </li> <li> <p>proportion of participants with BCVA 20/200 or worse (Snellen equivalent): the generally accepted definition of legal blindness in most countries. </p> </li> </ul> </p> <p>Due to the paucity of visual acuity outcome data available, we also included mean change in BCVA as a secondary outcome. When mean change in BCVA was not reported, we used mean BCVA at a follow‐up time point. </p> </section> </section> </section> <section id="CD007284-sec-0050"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007284-sec-0051"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (which contains the Cochrane Eyes and Vision Group Trials Register) 2013, Issue 7, part of <i>The Cochrane Library</i>. <a href="http://www.thecochranelibrary.com/" target="_blank">www.thecochranelibrary.com</a> (accessed 14 August 2013), Ovid MEDLINE, Ovid MEDLINE In‐Process and Other Non‐Indexed Citations, Ovid MEDLINE Daily, Ovid OLDMEDLINE (January 1946 to August 2013), EMBASE (January 1980 to August 2013), Latin American and Caribbean Health Sciences Literature Database (LILACS) (January 1982 to August 2013), the <i>meta</i> Register of Controlled Trials (<i>m</i>RCT) (<a href="http://www.controlled-trials.com/" target="_blank">www.controlled‐trials.com</a>), ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov/" target="_blank">www.clinicaltrials.gov</a>) and the WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://www.who.int/ictrp/search/en" target="_blank">www.who.int/ictrp/search/en</a>). We did not use any date or language restrictions in the electronic searches for trials. We last searched the electronic databases on 14 August 2013. </p> <p>See: Appendices for details of search strategies for CENTRAL (<a href="./appendices#CD007284-sec-0128">Appendix 1</a>), MEDLINE (<a href="./appendices#CD007284-sec-0129">Appendix 2</a>), EMBASE (<a href="./appendices#CD007284-sec-0130">Appendix 3</a>), LILACS (<a href="./appendices#CD007284-sec-0131">Appendix 4</a>), <i>m</i>RCT (<a href="./appendices#CD007284-sec-0132">Appendix 5</a>), ClinicalTrials.gov (<a href="./appendices#CD007284-sec-0133">Appendix 6</a>) and the ICTRP (<a href="./appendices#CD007284-sec-0134">Appendix 7</a>). </p> </section> <section id="CD007284-sec-0052"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of included studies to identify any additional trials. We also used the Science Citation Index ‐ Expanded database to identify additional trials that may have cited any studies that we included in the review. </p> </section> </section> <section id="CD007284-sec-0053"> <h3 class="title" id="CD007284-sec-0053">Data collection and analysis</h3> <section id="CD007284-sec-0054"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently reviewed the titles and abstracts of all records identified through the electronic searches. Each review author assessed records for eligibility and classified each record as 1) include, 2) unclear, or 3) exclude. We resolved discrepancies by discussion. We obtained the full‐text records for studies appearing to meet the inclusion criteria (1) or for which there were insufficient data in the title and abstract to make a clear decision (2). Two review authors independently assessed full‐text records obtained from all the electronic and other methods of searching to establish whether the studies met the inclusion criteria. We resolved discrepancies by discussion. When resolution was not possible, we consulted a third review author. Studies excluded after full‐text assessment appear in the <a href="./references#CD007284-sec-0145" title="">Characteristics of excluded studies</a> table with reasons for exclusion recorded. We attempted to contact trial investigators when data provided by the records were insufficient to include or exclude the study from the review. Studies for which we received no clarification from trial investigators are listed in the <a href="./references#CD007284-sec-0146" title="">Characteristics of studies awaiting classification</a> table. </p> </section> <section id="CD007284-sec-0055"> <h4 class="title">Data extraction and management</h4> <p>Two review authors independently extracted primary and secondary outcome findings for included studies onto paper data collection forms developed and piloted in collaboration with the Cochrane Eyes and Vision Group. We resolved discrepancies by discussion. We contacted trial investigators of included studies for missing data. Six weeks was provided for primary study investigators to respond. One review author entered all data into Review Manager 5 (<a href="./references#CD007284-bbs2-0041" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012. ">RevMan 2012</a>). A second review author verified the data entered. </p> <p>For each trial, we recorded the following:</p> <p> <ul id="CD007284-list-0003"> <li> <p>year of publication, country of origin, and source of study funding;</p> </li> <li> <p>details of the study methods relevant to assessing risks of bias;</p> </li> <li> <p>details of the participants including demographic characteristics and criteria for inclusion; </p> </li> <li> <p>details of the types of interventions;</p> </li> <li> <p>details of the outcomes reported, including method of assessment, and time intervals.</p> </li> </ul> </p> </section> <section id="CD007284-sec-0056"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed the risk of bias for the included trials as part of the data extraction process. We followed the tools for assessing risk of bias set forth in Chapter 8 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007284-bbs2-0033" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). </p> <p>We examined six main criteria for each study:</p> <p> <ol id="CD007284-list-0004"> <li> <p>adequate sequence generation;</p> </li> <li> <p>adequate allocation concealment;</p> </li> <li> <p>adequate masking of participants, personnel, and outcome assessors;</p> </li> <li> <p>incomplete outcome data adequately addressed;</p> </li> <li> <p>free of selective outcome reporting; and</p> </li> <li> <p>free of other sources of bias.</p> </li> </ol> </p> <p>We assessed each risk of bias criteria as:</p> <p> <ul id="CD007284-list-0005"> <li> <p>low risk of bias (plausible bias unlikely to seriously alter the results);</p> </li> <li> <p>unclear risk of bias (lack of information or uncertainty over the potential for bias); and </p> </li> <li> <p>high risk of bias (plausible bias that seriously weakens confidence in the results).</p> </li> </ul> </p> <p>We requested additional information from trial investigators when methods to access risks of bias were not reported. Further methodological assessments included sample size calculations, whether there was a clear explanation that final visual acuity took into account differential follow‐up, mention of the exclusion/inclusion criteria, adequate definitions of success criteria, and comparability of control and treatment groups at entry. </p> </section> <section id="CD007284-sec-0057"> <h4 class="title">Measures of treatment effect</h4> <p>When visual acuity was treated as a continuous outcome, we expressed treatment effect as a difference in means with 95% confidence intervals (CI). For dichotomous outcomes, we expressed the estimates of effect of an intervention as risk ratios (RR) with 95% CIs. Dichotomous outcomes included the proportion of participants whose BCVA improved at least five letters, the proportion of participants with BCVA 20/40 or better, the proportion of participants with BCVA 20/200 or worse (Snellen equivalent), the proportion of participants requiring additional interventions, the proportion of participants with PCO postoperatively, the proportion of participants with posterior synechiae, the proportion of participants with increased inflammation, the proportion of participants with an improvement in quality of life, and the proportion of participants with adverse events. </p> </section> <section id="CD007284-sec-0058"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual for two studies in which only one eye of each participant was included in the study. For two studies with an intra‐individual design, the unit of analysis was the eye for outcomes of visual acuity, PCO, additional postoperative interventions, and adverse events. Neither of these studies made appropriate adjustments for intra‐person correlation between eyes as described in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007284-bbs2-0027" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). We analyzed the data as available and noted the limitations with these interpretations. </p> <p>With respect to studies with more than two intervention arms, we analyzed data by the groups to which participants were randomized. This method results in multiple, correlated, pair‐wise comparisons for a given study. We have not adjusted for these correlations since no meta‐analysis was done. </p> </section> <section id="CD007284-sec-0059"> <h4 class="title">Dealing with missing data</h4> <p>At the review level, we attempted to contact trial investigators for any missing or unclear data. If investigators did not respond within six weeks, we extracted data as available from the published report. We referred to the guidelines for missing data in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007284-bbs2-0027" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). </p> <p>At the participant level, we reported the available‐case data assuming data were missing at random. We did not perform any imputation of data. </p> </section> <section id="CD007284-sec-0060"> <h4 class="title">Assessment of heterogeneity</h4> <p>We did not perform assessments of heterogeneity since we did not include meta‐analyzed estimates of the treatment effect in this review. If additional studies are added during future updates to this review, we will quantify the proportion of variability across the included studies that is not due to chance by using the I<sup>2</sup> statistic (<a href="./references#CD007284-bbs2-0033" title="HigginsJPT , AltmanDG , Sterne JAC(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). If the I<sup>2</sup> statistic is greater than 50%, we will consider there to be substantial statistical heterogeneity and will not combine the study results in a meta‐analysis. Instead, we will present the studies in a tabulated, narrative summary. We will investigate heterogeneity, if present, through subgroup analyses when data are available. </p> </section> <section id="CD007284-sec-0061"> <h4 class="title">Assessment of reporting biases</h4> <p>Since we did not include meta‐analyzed estimates of treatment effect across studies, we did not examine funnel plots to identify evidence of publication bias. </p> </section> <section id="CD007284-sec-0062"> <h4 class="title">Data synthesis</h4> <p>We did not perform meta‐analysis due to variability in reporting and follow‐up intervals for the primary and secondary outcomes of interest. If data synthesis is considered during a future update of this review, we will follow the guidelines for analysis set out in Chapter 9 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007284-bbs2-0027" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Deeks 2011</a>). We will calculate summary RRs for dichotomous outcomes when no substantial statistical heterogeneity is detected among included studies (an I<sup>2</sup> statistic 50% or less). If there is a small number of included studies (fewer than three), we will use the fixed‐effect model. We will use the random‐effects model for analyses with three or more studies. </p> </section> <section id="CD007284-sec-0063"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We found insufficient data to conduct subgroup analyses.</p> </section> <section id="CD007284-sec-0064"> <h4 class="title">Sensitivity analysis</h4> <p>We did not conduct sensitivity analyses to determine the impact of excluding studies with lower methodological quality, including exclusion of industry‐funded studies and unpublished studies since we included no studies in a meta‐analysis. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007284-sec-0065" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007284-sec-0065"></div> <section id="CD007284-sec-0066"> <h3 class="title">Description of studies</h3> <section id="CD007284-sec-0067"> <h4 class="title">Results of the search</h4> <p>The electronic searches identified 893 titles and abstracts as of 14 August 2013, of which 33 records appeared to be relevant (<a href="#CD007284-fig-0001">Figure 1</a>). We obtained the full‐text copies of the 33 records, which reported 22 unique studies. We included four studies (<a href="./references#CD007284-sec-0144" title="">Characteristics of included studies</a>), excluded 16 studies, and identified two potentially relevant registered trials. Currently, no reports of the registered trials have been published and no replies from the trial investigators have been received (<a href="./references#CD007284-bbs2-0023" title="NCT00001311 . Modified intraocular lens to reduce eye inflammation after cataract surgery in uveitis patients. clinicaltrials.gov/ct2/show/study/NCT00001311 (accessed 27 February 2014). ">NCT00001311</a>; <a href="./references#CD007284-bbs2-0022" title="NCT00000119 . Safety and efficacy of a heparin‐coated intraocular lens in uveitis. clinicaltrials.gov/show/NCT00000119 (accessed 27 February 2014). ">NCT00000119</a>). Based on available information, we have placed these two trials in the awaiting classification category and their descriptions are in the <a href="./references#CD007284-sec-0146" title="">Characteristics of studies awaiting classification</a> table. </p> <div class="figure" id="CD007284-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD007284-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007284.pub2/media/CDSR/CD007284/image_n/nCD007284-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>Additionally, we identified one potentially relevant citation from a review of the reference lists of included studies, but after retrieving the abstract, we excluded this study. Thus, 17 excluded studies are listed in the <a href="./references#CD007284-sec-0145" title="">Characteristics of excluded studies</a> table with reasons for exclusions. Searches of the Science Citation Index ‐ Expanded database as of 28 August 2013 did not yield any additional potentially relevant studies. </p> </section> <section id="CD007284-sec-0068"> <h4 class="title">Included studies</h4> <section id="CD007284-sec-0069"> <h5 class="title">Types of participants</h5> <p>The four studies included in this review enrolled 216 participants with uveitic cataract, with the largest enrolling 140 participants (<a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>). The <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> study was conducted at 19 international centers in Brazil, Egypt, Finland, France, Japan, the Netherlands, Slovak Republic, Spain, and the USA. Two studies, <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> and <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a>, were conducted in Germany and the <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> study was done in Saudi Arabia. In <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, participants were aged 18 and older and had quiescent (inactive) uveitis for at least three months prior to cataract surgery. After one year of follow‐up, outcomes for 64 men and 76 women were analyzed. <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> enrolled 60 non‐infectious uveitis participants (18 men and 42 women) with clinically significant lens opacities. </p> <p>The two other included trials involved participants with multiple comorbidities undergoing cataract surgery. <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> included people with diabetes mellitus with or without retinopathy, glaucoma, pseudoexfoliation, and uveitis; ages of participants were not listed. There were two people with uveitis among the 100 participants enrolled in the study. <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> included 14 people with uveitis (three men, 11 women), aged 11 to 66 years, among 25 participants with diabetes mellitus or inactive uveitis. </p> </section> <section id="CD007284-sec-0070"> <h5 class="title">Types of interventions</h5> <p><a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> randomized one eye of each participant to receive a hydrophobic acrylic (48 participants), silicone (44 participants), unmodified PMMA (26 participants), or HSM PMMA IOL (22 participants). <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> randomized one eye to receive a hydrophobic acrylic or hydrophilic acrylic IOL. <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> and <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> randomized one eye to receive a HSM PMMA IOL and the fellow eye to receive an unmodified PMMA IOL. </p> </section> <section id="CD007284-sec-0071"> <h5 class="title">Types of outcomes</h5> <p>The follow‐up times for the four included studies ranged from less than one month to 24 months after surgery. Two studies, <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> and <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a>, included visual acuity outcomes and reported the number of eyes requiring additional interventions, specifically Nd:YAG laser capsulotomy for PCO. Three studies, <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a>, and <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a>, reported the number of eyes developing PCO and the number of eyes developing posterior synechiae. All four included studies reported measures of postoperative inflammation. None of the included studies reported quality of life outcomes. </p> <p><a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> reported outcomes for BCVA (mean BCVA, categories of BCVA, and number of Snellen lines gained or lost), postoperative inflammation, PCO, relapses, and other clinical observations (i.e. corneal edema, CME, pupillary membrane crossing, posterior synechiae, giant and small cells on the IOL optic, pigment deposits, and IOL decentration) at one year' follow‐up. <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> reported BCVA (mean BCVA and two or more lines of improvement), uveal biocompatibility (giant cells on IOL, anterior chamber cells, laser flare photometry, and posterior synechiae), and capsular biocompatibility (PCO, number of Nd:YAG laser capsulotomies, and lens epithelial cell outgrowth) at one, three, and six months after surgery. Adverse events including endophthalmitis, elevated intraocular pressure, and macular edema were also reported. </p> <p><a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> reported outcomes for posterior synechiae, IOL cellular deposits, posterior capsular fibrosis, and anterior chamber reaction assessments six months after surgery. <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> reported the mean difference (MD) between preoperative flare and follow‐up assessments at one day, one week, six weeks, and three months after surgery. </p> </section> </section> <section id="CD007284-sec-0072"> <h4 class="title">Excluded studies</h4> <p>We excluded 17 studies and the reasons for exclusion may be found in the <a href="./references#CD007284-sec-0145" title="">Characteristics of excluded studies</a> table. Thirteen studies were not RCTs, three studies excluded people with uveitis, and one study did not specify the types of IOLs used. </p> </section> </section> <section id="CD007284-sec-0073"> <h3 class="title">Risk of bias in included studies</h3> <p><a href="#CD007284-fig-0002">Figure 2</a> shows the risk of bias assessments for all included studies. Details for each risk of bias parameter by study are provided in the <a href="./references#CD007284-sec-0144" title="">Characteristics of included studies</a> table. </p> <div class="figure" id="CD007284-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD007284-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007284.pub2/media/CDSR/CD007284/image_n/nCD007284-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD007284-sec-0074"> <h4 class="title">Allocation</h4> <section id="CD007284-sec-0075"> <h5 class="title">Sequence generation</h5> <p><a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> employed a complete block design; data coordinating center staff were responsible for generating the random assignments. <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a>, <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a>, and <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> used a computer to generate random assignments. </p> </section> <section id="CD007284-sec-0076"> <h5 class="title">Allocation concealment</h5> <p><a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> used a complete block design with IOL assignment in sequentially numbered, sealed envelopes. In the <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> study, IOLs were concealed in boxes and opened during the procedure by an unmasked operating room nurse. <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> and <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> reported using sealed envelopes. </p> </section> <section id="CD007284-sec-0077"> <h5 class="title">Masking (performance bias and detection bias)</h5> <p>In <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, participants, surgeons, and outcome assessors were not masked to treatment assignment. In <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a>, participants and surgeons (same surgeons treated and followed participants) were masked to treatment assignment. The research coordinator and operating room nurse were unmasked. <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> reported that participants were masked. <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> noted that surgeons and outcome assessors could not be masked due to obvious differences in IOL design. </p> </section> </section> <section id="CD007284-sec-0078"> <h4 class="title">Incomplete outcome data</h4> <p>In <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, of 170 people screened for the trial, 140 met the enrollment criteria and completed one year of follow‐up. It is unknown whether there were additional enrolled participants who were not included in the report because they did not complete the one year' follow‐up exam. In <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a>, three people with uveitis (6 eyes) missed the six‐month follow‐up visit and were not included in the final analyses (based on correspondence with the lead study author) and even after considering this exclusion, reports of PCO were reported for only 19 of the remaining 22 eyes. <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> did not report losses or exclusions, but numbers and percentages of participants with visual acuity outcomes of interest suggested that data were missing for four eyes in the hydrophobic acrylic lens group and for one eye in the hydrophilic acrylic lens group at three months and five eyes in the hydrophobic acrylic lens group and six eyes in the hydrophilic acrylic lens group at six months. There were no apparent losses or exclusions in <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a>. </p> </section> <section id="CD007284-sec-0079"> <h4 class="title">Selective reporting</h4> <p>There was insufficient information to determine whether any of the included studies were at high or low risk of bias due to selective outcome reporting. </p> </section> <section id="CD007284-sec-0080"> <h4 class="title">Other potential sources of bias</h4> <p>There was insufficient information to determine whether there were other potential sources of bias. </p> </section> </section> <section id="CD007284-sec-0081"> <h3 class="title" id="CD007284-sec-0081">Effects of interventions</h3> <p>The variability of interventions and outcomes (timing and measurement) among studies precluded meta‐analysis. We report, instead, summaries of study results by comparisons of IOL types. </p> <section id="CD007284-sec-0082"> <h4 class="title">Acrylic versus silicone intraocular lenses</h4> <section id="CD007284-sec-0083"> <h5 class="title">Visual acuity</h5> <p>One study, <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, compared hydrophobic acrylic IOLs (48 participants) with silicone IOLs (44 participants). The proportion of participants with one or more Snellen lines of visual improvement (equivalent of gaining five or more letters on the ETDRS visual acuity chart) in the study eye was similar between treatment groups at one year' follow‐up: 45 of 48 (94%) eyes in the acrylic IOL group and 39 of 44 (89%) eyes in the silicone IOL group (RR 1.06, 95% CI 0.93 to 1.20) (<a href="#CD007284-tbl-0001">Table 1</a>). </p> <div class="table" id="CD007284-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Visual acuity outcomes at one year by intraocular lens types in Alió 2002 study</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Type of IOLs compared</b> </p> <p><b>(number of participants)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BCVA, measured as Snellen equivalent</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>≥ 1 lines gained<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>≥ 20/40<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>≤ 20/200<br/> RR (95% CI)**</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean BCVA<br/> (Mean ± number of lines)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.93 to 1.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.06 (1.20 to 3.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57 (0.20 to 1.62)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/80 ± 2) versus (20/160 ± 1) (P value = 0.006)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus unmodified PMMA (26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.11 (0.93 to 1.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.13 (0.71 to 1.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.68 (0.20 to 2.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/80 ± 2) versus (20/100 ± 2) (P value ≥ 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus HSM PMMA (22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.15 (0.93 to 1.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.13 (0.69 to 1.83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 (0.15 to 1.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/80 ± 2) versus (20/120 ± 2) (P value ≥ 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unmodified (26) PMMA versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 (0.79 to 1.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83 (0.99 to 3.40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85 (0.28 to 2.54)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/100 ± 2) versus (20/160 ± 1) (P value = 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HSM PMMA (22) versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92 (0.74 to 1.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83 (0.97 to 3.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25 (0.46 to 3.38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/120 ± 2) versus (20/160 ± 1) (P value ≥ 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unmodified (26) PMMA versus HSM PMMA (22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 (0.80 to 1.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.57 to 1.76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.68 (0.21 to 2.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/100 ± 2) versus (20/120 ± 2) (P value ≥ 0.05)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>BCVA: best‐corrected visual acuity; CI: confidence interval; HSM: heparin‐surface modified; IOL: intraocular lens; PMMA: poly(methyl methacrylate); RR: risk ratio. </p> <p>*RRs &gt; 1 favor the test IOL type and RRs &lt; 1 favor the comparison IOL type.<br/> **RRs &lt; 1 favor the test IOL type and RRs &gt; 1 favor the comparison IOL type. </p> </div> </div> <p>Mean BCVA at one year was significantly improved in eyes with acrylic IOLs (20/80 ± 2) when compared with silicone IOLs (20/160 ± 1) (P value = 0.006). We did not transform mean BCVA (± standard deviation) values to calculate a between‐group difference because the Snellen scale is not linear. Participants in the acrylic IOL group were twice as likely to achieve BCVA of 20/40 or better in the study eye compared with participants in the silicone IOL group (RR 2.06, 95% CI 1.20 to 3.55). Five of 48 (10%) eyes in the acrylic IOL group and 8 of 44 (18%) eyes in the silicone IOL group had BCVA of 20/200 or worse (RR 0.57, 95% CI 0.20 to 1.62) (<a href="#CD007284-tbl-0001">Table 1</a>). </p> </section> <section id="CD007284-sec-0084"> <h5 class="title">Additional interventions</h5> <p><a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> reported the number of eyes requiring additional interventions, specifically Nd:YAG laser capsulotomy for PCO. Up to one year of follow‐up, a capsulotomy had been performed in 2 of 48 (4%) eyes randomized to acrylic IOLs (one each at three and six months) and 3 of 44 (7%) eyes randomized to silicone IOLs (two at three months and one at one year). Because of the small number of events in both groups, the 95% CI for this result was wide and the results may be unreliable (RR 0.61, 95% CI 0.11 to 3.49) (<a href="#CD007284-tbl-0002">Table 2</a>). </p> <div class="table" id="CD007284-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Adverse outcomes at one year by intraocular lens types in Alió 2002 study</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Type of IOLs compared</b> </p> <p><b>(number of participants)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Additional<br/> interventions<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PCO<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Posterior<br/> synechiae<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Postoperative<br/> inflammation<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Corneal edema<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CME<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mild IOL<br/> decentration<br/> RR (95% CI)*</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61 (0.11 to 3.49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74 (0.41 to 1.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.18 (0.04 to 0.79)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72 (0.49 to 1.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.49 (0.22 to 1.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.10 (0.01 to 1.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92 (0.06 to 14.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus unmodified PMMA (26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.76 (0.14 to 55.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78 (0.39 to 1.58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.76 (0.14 to 55.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74 (0.48 to 1.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.79 (0.49 to 29.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.18 (0.01 to 4.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.65 (0.07 to 39.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus HSM PMMA (22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.35 (0.12 to 46.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 (0.31 to 1.14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 (0.07 to 3.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.26 (0.67 to 2.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.07 (0.30 to 3.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in both groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.41 (0.06 to 33.26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unmodified (26) PMMA versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.24 (0.01 to 4.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 (0.49 to 1.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 (0.00 to 1.30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 (0.66 to 1.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.13 (0.02 to 0.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.42 (0.05 to 3.59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.56 (0.02 to 13.16)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HSM PMMA (22) versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.28 (0.02 to 5.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25 (0.68 to 2.28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40 (0.10 to 1.67)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57 (0.31 to 1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 (0.15 to 1.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22 (0.01 to 3.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.65 (0.03 to 15.39)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unmodified (26) PMMA versus HSM PMMA (22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in both groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.76 (0.38 to 1.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17 (0.01 to 3.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.69 (0.90 to 3.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.28 (0.03 to 2.52)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.56 (0.11 to 59.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in both groups</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; CME: cystoid macular edema; HSM: heparin‐surface modified; IOL: intraocular lens; PCO: posterior capsule opacification; PMMA: poly(methyl methacrylate); RR: risk ratio.<br/> <br/> *RRs &lt; 1 favor the test IOL type and RRs &gt; 1 favor the comparison IOL type. </p> </div> </div> </section> <section id="CD007284-sec-0085"> <h5 class="title">Posterior capsule opacification</h5> <p>At six months' follow‐up, <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> reported that there were statistically fewer eyes developing PCO in the acrylic IOL group than the silicone IOL group (P value = 0.047; proportions not reported); however, by one year' follow‐up, there was no statistically significant difference observed between groups as 13 of 48 (27%) eyes randomized to acrylic IOLs and 16 of 44 (36%) eyes randomized to silicone IOLs developed PCO of any grade (RR 0.74, 95% CI 0.41 to 1.37) (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0086"> <h5 class="title">Posterior synechiae</h5> <p><a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> reported the number of eyes developing posterior synechiae. At one year' follow‐up, fewer eyes developed posterior synechiae of any severity among those with acrylic IOLs (2 of 48, 4%) when compared with those with silicone IOLs (10 of 44, 23%) (RR 0.18, 95% CI 0.04 to 0.79) (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0087"> <h5 class="title">Postoperative inflammation</h5> <p><a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> defined "an increase in the inflammatory recording of 2 degrees in Uveitic Scoring System scoring at two separate visits or at an unscheduled visit" as a relapse. Twenty‐two of 48 (46%) eyes randomized to acrylic IOLs and 28 of 44 (64%) eyes with silicone IOLs experienced one or two relapses during the course of the one‐year study (RR 0.72, 95% CI 0.49 to 1.05). A related measurement of postoperative inflammation was their grading of anterior chamber cell (inflammation) on postoperative days 1, 4, 7, and 15. The acrylic group had significantly less postoperative inflammation than the silicone group at days 1, 4, 7, and 15 (P value &lt; 0.03 at all time points; proportions not reported) (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0088"> <h5 class="title">Adverse events</h5> <p>Corneal edema developed in 7 of 48 (15%) eyes randomized to acrylic IOLs and 13 of 44 (30%) eyes with silicone IOLs (RR 0.49, 95% CI 0.22 to 1.12). None of 48 (0%) eyes in the acrylic IOL group compared with 4 of 44 (9%) eyes in the silicone IOL group developed CME (RR 0.10, 95% CI 0.01 to 1.84). One of 48 (0%) eyes with an acrylic IOL and 1 of 44 (2%) eyes with a silicone IOL experienced mild IOL decentration (RR 0.92, 95% CI 0.06 to 14.22) (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> </section> <section id="CD007284-sec-0089"> <h4 class="title">Acrylic versus poly(methyl methacrylate) intraocular lenses</h4> <section id="CD007284-sec-0090"> <h5 class="title">Visual acuity</h5> <p>One study, <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, compared hydrophobic acrylic IOLs (48 participants) with unmodified hydrophobic PMMA IOLs (26 participants) and hydrophilic heparin surface modified (HSM) PMMA IOLs (22 participants). At one year' follow‐up, the proportion of participants with one or more Snellen lines of visual improvement (equivalent of gaining five or more letters on the ETDRS visual acuity chart) in the study eye was similar in acrylic IOL group (45 of 48, 94%) compared with the unmodified PMMA IOL group (22 of 26, 85%) (RR 1.11, 95% CI 0.93 to 1.33) and the HSM PMMA IOL group (18 of 22, 82%) (RR 1.15, 95% CI 0.93 to 1.41) (<a href="#CD007284-tbl-0001">Table 1</a>). </p> <p>Mean BCVA at one year was not significantly different among eyes with acrylic IOLs (20/80 ± 2) when compared with unmodified PMMA IOLs (20/100 ± 2) or HSM PMMA IOLs (20/120 ± 2). The proportion of participants with BCVA of 20/40 or better in the study eye was similar between the acrylic IOL group and unmodified PMMA IOL group (RR 1.13, 95% CI 0.71 to 1.78) and between the acrylic IOL group and HSM PMMA IOL group (RR 1.13, 95% CI 0.69 to 1.83). Five of 48 (10%) eyes in the acrylic IOL group versus 4 of 26 (15%) eyes in the unmodified PMMA IOL group (RR 0.68, 95% CI 0.20 to 2.31) and 5 of 22 (23%) eyes in the HSM PMMA IOL group (RR 0.46, 95% CI 0.15 to 1.42) had BCVA of 20/200 or worse (<a href="#CD007284-tbl-0001">Table 1</a>). </p> </section> <section id="CD007284-sec-0091"> <h5 class="title">Additional interventions</h5> <p><a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> reported the number of eyes requiring Nd:YAG laser capsulotomy for PCO. Up to one year of follow‐up, a capsulotomy had been performed in 2 of 48 (4%) eyes randomized to acrylic IOLs (one each at three and six months) versus 0 of 26 (0%) eyes in the unmodified PMMA IOL (RR 2.76, 95% CI 0.14 to 55.33) or 0 of 22 (0%) eyes in the HSM PMMA IOL (RR 2.35, 95% CI 0.12 to 46.94) groups (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0092"> <h5 class="title">Posterior capsule opacification</h5> <p>At one year' follow‐up, 13 of 48 eyes (27%) randomized to acrylic IOLs versus 9 of 26 (35%) randomized to unmodified PMMA IOLs (RR 0.78, 95% CI 0.39 to 1.58), and 10 of 22 (45%) randomized to HSM PMMA IOLs (RR 0.60, 95% CI 0.31 to 1.14) developed PCO of any grade (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0093"> <h5 class="title">Posterior synechiae</h5> <p>At one year' follow‐up, 2 of 48 (4%) eyes randomized to acrylic IOLs versus 0 of 26 (0%) eyes randomized to unmodified PMMA IOLs (RR 2.76, 95% CI 0.14 to 55.33) and 2 of 22 (9%) randomized to HSM PMMA IOLs (RR 0.46, 95% CI 0.07 to 3.05) developed posterior synechiae of any severity (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0094"> <h5 class="title">Postoperative inflammation</h5> <p>During the course of one year, 22 of 48 (46%) eyes randomized to acrylic IOLs versus 16 of 26 (62%) eyes with unmodified PMMA IOLs (RR 0.74, 95% CI 0.48 to 1.15) and 8 of 22 (36%) eyes with HSM PMMA IOLs (RR 1.26, 95% CI 0.67 to 2.37) experienced one or two relapses, defined as "an increase in the inflammatory recording of 2 degrees in Uveitic Scoring System scoring at two separate visits or at an unscheduled visit". One day postoperatively, anterior chamber cell grades were significantly lower in the acrylic IOL group than in the HSM PMMA group (P value = 0.026; proportions not reported); however, at all subsequent time points the trial authors reported there were no differences between groups (no quantitative data reported). The trial authors reported no significant differences in postoperative inflammation between the acrylic IOL group and the unmodified PMMA group at any period (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0095"> <h5 class="title">Adverse events</h5> <p>Corneal edema developed in 7 of 48 (15%) eyes randomized to acrylic IOLs versus 1 of 26 (4%) eyes randomized to unmodified PMMA IOLs (RR 3.79, 95% CI 0.49 to 29.17) and 3 of 22 (14%) eyes randomized to HSM PMMA IOLs (RR 1.07, 95% CI 0.30 to 3.75). None of 48 (0%) eyes in the acrylic IOL group compared with 1 of 26 (4%) eyes in the unmodified PMMA IOL group (RR 0.18, 95% CI 0.01 to 4.36) developed CME. None of 22 (0%) eyes in the HSM PMMA IOL group developed CME. One of 48 (0%) eyes with an acrylic IOL, 0 of 26 (0%) eyes in the unmodified PMMA IOL, and 0 of 22 (0%) eyes in the HSM PMMA IOL group experienced mild IOL decentration (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> </section> <section id="CD007284-sec-0096"> <h4 class="title">Poly(methyl methacrylate) versus silicone intraocular lenses</h4> <section id="CD007284-sec-0097"> <h5 class="title">Visual acuity</h5> <p>One study, <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, compared unmodified hydrophobic PMMA IOLs (26 participants) or hydrophilic HSM PMMA IOLs (22 participants) with silicone IOLs (44 participants) (<a href="#CD007284-tbl-0001">Table 1</a>). </p> <p>At one year' follow‐up, the proportion of participants with one or more Snellen lines of visual improvement (equivalent of gaining five or more letters on the ETDRS visual acuity chart) in the study eye was similar when comparing the unmodified PMMA IOL group (22 of 26, 85%) with the silicone IOL group (39 of 44, 89%) (RR 0.95, 95% CI 0.79 to 1.16) and the HSM PMMA IOL group (18 of 22, 82%) with the silicone IOL group (RR 0.92, 95% CI 0.74 to 1.15) (<a href="#CD007284-tbl-0001">Table 1</a>). </p> <p>Mean BCVA at one year was reported to be significantly better among eyes with unmodified PMMA IOLs (20/100 ± 2) when compared with eyes with silicone IOLs (20/160 ± 1) (P value = 0.05). No significant difference was reported between eyes with HSM PMMA IOLs (20/120 ± 2) and eyes with silicone IOLs. The improvement in BCVA in eyes with unmodified PMMA IOLs (RR 1.83, 95% CI 0.99 to 3.40) or HSM PMMA IOLs (RR 1.83, 95% CI 0.97 to 3.47) was compatible with no difference and a substantial increase in BCVA of 20/40 or greater at one year when compared with eyes with silicone IOLs. Four of 26 (15%) eyes in the unmodified PMMA IOL group and 8 of 44 (18%) eyes in the silicone group had BCVA of 20/200 or worse (RR 0.85, 95% CI 0.28 to 2.54). Five of 22 (23%) eyes in the HSM PMMA IOL group compared with 4 of 44 (9%) in the silicone group had BCVA of 20/200 or worse (RR 1.25, 95% CI 0.46 to 3.38) (<a href="#CD007284-tbl-0001">Table 1</a>). </p> </section> <section id="CD007284-sec-0098"> <h5 class="title">Additional interventions</h5> <p>Up to one year of follow‐up, a capsulotomy had been performed in 0 of 26 (0%) eyes in the unmodified PMMA IOL (RR 0.24, 95% CI 0.01 to 4.43) and 0 or 22 (0%) eyes in the HSM PMMA IOL (RR 0.28, 95% CI 0.02 to 5.18) groups compared with 3 of 44 (7%) eyes randomized to silicone IOLs, two at three months and one at one year (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0099"> <h5 class="title">Posterior capsule opacification</h5> <p><a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> reported that at six months there were a statistically fewer eyes developing PCO in the HSM PMMA IOL group than the silicone IOL group (P value = 0.05; proportions not reported). At one year' follow‐up, 9 of 26 (35%) eyes randomized to unmodified PMMA IOLs (RR 0.95, 95% CI 0.49 to 1.84) and 10 of 22 (45%) eyes randomized to HSM PMMA IOLs (RR 1.25, 95% CI 0.68 to 2.28) developed PCO of any grade compared with 16 of 44 (36%) eyes randomized to silicone IOLs (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0100"> <h5 class="title">Posterior synechiae</h5> <p>At one year' follow‐up, 0 of 26 (0%) eyes randomized to unmodified PMMA IOLs (RR 0.08, 95% CI 0.00 to 1.30) and 2 of 22 (9%) eyes randomized to HSM PMMA IOLs (RR 0.40, 95% CI 0.10 to 1.67) developed posterior synechiae of any severity compared with 10 of 44 (23%) eyes in the silicone IOL group (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0101"> <h5 class="title">Postoperative inflammation</h5> <p>During the course of one year, 16 of 26 (62%) eyes with unmodified PMMA IOLs (RR 0.97, 95% CI 0.66 to 1.41) and 8 of 22 (36%) eyes with HSM PMMA IOLs (RR 0.57, 95% CI 0.31 to 1.04) experienced one or two relapses compared with 28 of 44 (64%) eyes with silicone IOLs. At one day, inflammation was reported to be significantly less in the unmodified PMMA group than in the silicone group (P value = 0.046; proportions not reported). There were no other significant differences among groups at any time (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0102"> <h5 class="title">Adverse events</h5> <p>Corneal edema developed in 1 of 26 (4%) eyes randomized to unmodified PMMA IOLs (RR 0.13, 95% CI 0.02 to 0.94) and 3 of 22 (14%) eyes randomized to HSM PMMA IOLs (RR 0.46, 95% CI 0.15 to 1.45) compared with 13 of 44 (30%) eyes randomized to silicone IOLs. One of 26 (4%) eyes in the unmodified PMMA IOL group (RR 0.42, 95% CI 0.05 to 3.59) and 0 of 22 (0%) eyes in the HSM PMMA IOL group (RR 0.22, 95% 0.01 to 3.87) developed CME compared with 4 of 44 (9%) eyes in the silicone group. None of 26 (0%) eyes in the unmodified PMMA IOL group and 0 of 22 (0%) eyes in the HSM PMMA group experienced mild IOL decentration compared with 1 of 44 (2%) eyes in the silicone group (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> </section> <section id="CD007284-sec-0103"> <h4 class="title">Unmodified versus heparin surface modified poly(methyl methacrylate) intraocular lenses</h4> <section id="CD007284-sec-0104"> <h5 class="title">Visual acuity</h5> <p>Three studies, <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a>, and <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a>, compared unmodified hydrophobic PMMA IOLs with hydrophilic HSM PMMA IOLs. In <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, 26 participants were randomized to unmodified PMMA IOLs and 22 participants were randomized to HSM PMMA IOLs with one study eye per participant (<a href="#CD007284-tbl-0001">Table 1</a>). <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> and <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> were paired‐eye studies in which one eye of each participant was randomized to receive an unmodified PMMA IOL and the fellow eye received an HSM PMMA IOL. Both paired‐eye studies included participants undergoing cataract surgery due to various etiologies, with four eyes of two participants from <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> and 28 eyes of 14 participants from <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> diagnosed with uveitis. </p> <p>At one year follow‐up in <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, the proportion of participants with one or more Snellen lines of visual improvement (equivalent of gaining five or more letters on the ETDRS visual acuity chart) in the study eye was similar between the unmodified PMMA IOL group (22 of 26, 85%) and the HSM PMMA IOL group (18 of 22, 82%) (RR 1.03, 95% CI 0.80 to 1.34). Mean BCVA at one year was not significantly different among eyes with unmodified PMMA IOLs (20/100 ± 2) or HSM PMMA IOLs (20/120 ± 2). The proportion of participants with BCVA of 20/40 or better in the study eye was similar between the unmodified PMMA IOL group and the HSM PMMA IOL group (RR 1.00, 95% CI 0.57 to 1.76). Four of 26 (15%) eyes in the unmodified PMMA IOL group and five of 22 (23%) eyes in the HSM PMMA IOL group had BCVA of 20/200 or worse (RR 0.68, 95% CI 0.21 to 2.22) (<a href="#CD007284-tbl-0001">Table 1</a>). </p> <p><a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> and <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> did not report visual acuity outcomes. </p> </section> <section id="CD007284-sec-0105"> <h5 class="title">Additional interventions</h5> <p><a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> reported no capsulotomies for PCO had been performed in eyes in either the unmodified PMMA IOL or HSM PMMA IOL groups at one year' follow‐up (<a href="#CD007284-tbl-0002">Table 2</a>). <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> and <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> did not report outcomes for additional interventions. </p> </section> <section id="CD007284-sec-0106"> <h5 class="title">Posterior capsule opacification</h5> <p>At six months' follow‐up in <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a>, 5 of 9 (56%) eyes randomized to unmodified PMMA IOLs and 6 of 10 (60%) eyes randomized to HSM PMMA IOLs developed PCO (RR 0.93, 95% CI 0.43 to 2.01; no adjustments made for the non‐independence of eyes). </p> <p>At one year follow‐up in <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, 9 of 26 (35%) eyes randomized to unmodified PMMA IOLs versus 10 of 22 (45%) eyes randomized to HSM PMMA IOLs developed PCO of any grade (RR 0.76, 95% CI 0.38 to 1.53) (<a href="#CD007284-tbl-0002">Table 2</a>). </p> <p><a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> did not report the number of eyes developing PCO. </p> </section> <section id="CD007284-sec-0107"> <h5 class="title">Posterior synechiae</h5> <p>At six months' follow‐up in <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a>, 2 of 11 (18%) eyes in the unmodified PMMA IOL group and 1 of 11 (9%) eyes in the HSM PMMA IOL group developed posterior synechiae (RR 2.00, 95% CI 0.21 to 18.98). </p> <p>At one year' follow‐up in <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, 0 of 26 (0%) eyes randomized to unmodified PMMA IOLs compared with 2 of 22 (9%) eyes randomized to HSM PMMA IOLs developed posterior synechiae of any severity (RR 0.17, 95% CI 0.01 to 3.37) (<a href="#CD007284-tbl-0002">Table 2</a>). </p> <p><a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> did not report the number of eyes developing posterior synechiae. </p> </section> <section id="CD007284-sec-0108"> <h5 class="title">Postoperative inflammation</h5> <p>At three months in the <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> study, the mean (standard deviation) difference in preoperative and three‐month postoperative flare of two eyes with unmodified PMMA IOLs was 4.6 ± 0.6 photon counts/millisecond; the difference between the two eyes with HSM PMMA IOLs was ‐0.3 ± 10.8 (MD 4.90, 95% CI ‐10.09 to 19.89). </p> <p>At six months in the <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> study, 7 of 11 (64%) eyes randomized to unmodified PMMA IOLs versus 4 of 11 (36%) eyes randomized to HSM PMMA IOLs developed more than three cells on the anterior surface of the IOL. This difference was not statistically significant (RR 1.75, 95% CI 0.71 to 4.31). </p> <p>During the course of one year in the <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> study, 16 of 26 (62%) eyes with unmodified PMMA IOLs compared with 8 of 22 (36%) eyes with HSM PMMA IOLs experienced one or two relapses, defined as "an increase in the inflammatory recording of 2 degrees in Uveitic Scoring System scoring at two separate visits or at an unscheduled visit" (RR 1.69, 95% CI 0.90 to 3.18). The trial authors reported no significant differences in postoperative inflammation between the unmodified PMMA IOL group and HSM PMMA IOL group at any period (<a href="#CD007284-tbl-0002">Table 2</a>). </p> </section> <section id="CD007284-sec-0109"> <h5 class="title">Adverse events</h5> <p>Additional adverse events were reported in <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>. Corneal edema developed in 1 of 26 (4%) eyes randomized to unmodified PMMA IOLs and 3 of 22 (14%) eyes randomized to HSM PMMA IOLs (RR 0.28, 95% CI 0.03 to 2.52). One of 26 (4%) eyes in the unmodified PMMA IOL group compared with 0 of 22 (0%) eyes in the HSM PMMA IOL group developed CME (RR 2.56, 95% CI 0.11 to 59.75). No eyes in either group experienced mild IOL decentration (<a href="#CD007284-tbl-0002">Table 2</a>). </p> <p><a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> and <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> did not report additional complications. </p> </section> </section> <section id="CD007284-sec-0110"> <h4 class="title">Hydrophobic versus hydrophilic acrylic intraocular lenses</h4> <section id="CD007284-sec-0111"> <h5 class="title">Visual acuity</h5> <p>One study, <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a>, compared hydrophobic acrylic IOLs (30 participants) with hydrophilic acrylic IOLs (30 participants). At three months' follow‐up visual acuity data were available for 26 of 30 (87%) participants in the hydrophobic acrylic IOL group and 29 of 30 (97%) participants in the hydrophilic acrylic IOL group. At six months' follow‐up visual acuity data were available for 25 of 30 (83%) participants in the hydrophobic acrylic IOL group and 24 of 30 (80%) participants in the hydrophilic acrylic IOL group. </p> <p>At three months, 24 of 26 (92%) eyes in the hydrophobic acrylic IOL group versus 26 of 29 (90%) eyes randomized to hydrophilic acrylic lenses had improvements in BCVA of two or greater Snellen lines (RR 1.03, 95% CI 0.87 to 1.22), suggesting no statistical or clinical difference between hydrophobic and hydrophilic acrylic IOL types. This outcome was maintained at six months: 21 of 25 (84%) eyes randomized to hydrophobic acrylic lenses versus 22 of 24 (92%) eyes randomized to hydrophilic acrylic lenses had improvements in BCVA of two or greater Snellen lines (RR 0.92, 95% CI 0.74, 1.13). </p> <p>Mean BCVA did not significantly differ between group at three (MD 0.13 LogMAR, 95% CI ‐0.03 to 0.29) or six months (MD 0.10 LogMAR, 95% CI ‐0.08 to 0.28). <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> did not report outcomes for BCVA 20/40 or better or for BCVA 20/200 or worse. </p> </section> <section id="CD007284-sec-0112"> <h5 class="title">Additional interventions</h5> <p><a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> reported the number of eyes requiring additional interventions, specifically Nd:YAG laser capsulotomy for PCO. At six months, a capsulotomy had been performed in 6 of 30 (20%) eyes randomized to hydrophobic acrylic IOLs and 4 of 30 (13%) eyes randomized to hydrophilic IOLs (RR 1.50, 95% CI 0.47 to 4.78). </p> </section> <section id="CD007284-sec-0113"> <h5 class="title">Posterior capsule opacification</h5> <p>At three months' follow‐up, 17 of 30 (57%) eyes randomized to hydrophobic acrylic IOLs developed PCO compared with 22 of 30 (73%) eyes randomized to hydrophilic IOLs at three months (RR 0.77, 95% CI 0.53 to 1.13). An equal number of eyes developed PCO in both groups at six months (25 of 30 (83%) eyes in each group) (RR 1.00, 95% CI 0.80 to 1.25) (<a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a>). </p> </section> <section id="CD007284-sec-0114"> <h5 class="title">Posterior synechiae</h5> <p>Over the course of the <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> study, 1 of 30 (3%) eyes randomized to the hydrophobic IOL group and 2 of 30 (6%) eyes randomized to the hydrophilic IOL group developed posterior synechiae (RR 0.50, 95% CI 0.05 to 5.22). </p> </section> <section id="CD007284-sec-0115"> <h5 class="title">Postoperative inflammation</h5> <p><a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> reported the development of laser flare, anterior chamber cells, and giant cells on the anterior surface of the IOL. There were no differences reported in laser flare and anterior chamber cells at three and six months. Although the difference in giant cell deposits at three months was not significant (data not reported), at six months, eyes with hydrophobic acrylic IOLs (13 of 30 eyes, 42%) were 6.5 times more likely than eyes with hydrophilic acrylic IOLs (2 of 30 eyes, 8%) to have had giant cells graded as 1+ or more (RR 6.50, 95% 1.60 to 26.36). Three of 30 (10%) eyes with hydrophobic acrylic IOLs and 4 of 30 (13%) eyes with hydrophilic acrylic IOLs experienced reactivation of inflammation during the study (RR 0.75, 95% CI 0.18 to 3.07). </p> </section> <section id="CD007284-sec-0116"> <h5 class="title">Adverse events</h5> <p>In <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a>, 8 of 30 (27%) eyes with hydrophobic acrylic IOLs and 7 of 30 (23%) eyes with hydrophilic acrylic IOLs developed macular edema (RR 1.14, 95% CI 0.47 to 2.75); and 2 of 30 (7%) eyes with hydrophobic acrylic IOLs and 3 of 30 (10%) eyes with hydrophilic acrylic IOLs developed intraocular pressures of 22 mmHg or greater (RR 0.67, 95% CI 0.12 to 3.71). No eyes experienced IOL decentration, IOL dislocation, endophthalmitis, retinal detachment, or IOL exchange. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007284-sec-0117" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007284-sec-0117"></div> <section id="CD007284-sec-0118"> <h3 class="title" id="CD007284-sec-0118">Summary of main results</h3> <p>We identified four studies meeting the eligibility criteria for this review. The largest study suggested the use of hydrophobic acrylic IOLs over silicone IOLs in people over the age of 18 years with a history of uveitis in terms of improved BCVA (<a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>) (<a href="#CD007284-tbl-0001">Table 1</a>). At one year, eyes randomized to hydrophobic acrylic IOLs were 2.06 times more likely (95% CI 1.20 to 3.55) to have had BCVA of 20/40 or greater when compared with eyes randomized to silicone IOLs; however, when visual acuity was measured as the proportion of participants with one or more Snellen lines of visual improvement, a difference between hydrophobic acrylic and silicone IOLs was not observed (RR 1.06, 95% CI 0.93 to 1.20). Fewer eyes with hydrophobic acrylic IOLs developed posterior synechiae of any severity or experienced postoperative inflammation compared with eye with silicone IOLs (<a href="#CD007284-tbl-0002">Table 2</a>). Eyes randomized to hydrophobic acrylic IOLs were reported to have been less likely to develop PCO six months postsurgery compared with eyes randomized to silicone IOLs (data not reported); however, this difference was less certain after one year (RR 0.74, 95% CI 0.41 to 1.37). Eyes randomized to hydrophobic acrylic IOLs also showed less postoperative inflammation compared with eyes randomized to silicone IOLs at 1, 4, 7, and 15 days after surgery. These two lens types were similar with respect to the proportions of participants requiring capsulotomy or experiencing other adverse events. </p> <p>In addition to acrylic and silicone IOLs, the <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> study investigated unmodified PMMA IOLs and HSM PMMA IOLs. Two other studies, <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> and <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a>, also compared unmodified PMMA IOLs and HSM PMMA IOLs. There were no statistically significant differences in outcomes among eyes of people randomized to receive HSM IOLs when compared with fellow eyes receiving PMMA IOLs; however, the small numbers of participants receiving these lens types may preclude the power to detect statistical differences between groups. </p> <p>One study, <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a>, compared hydrophobic acrylic IOLs with hydrophilic acrylic IOLs. At six months, the effects of the lens types in terms of BCVA, PCO, posterior synechiae, laser flare, or anterior chamber cells were uncertain due to a small sample size and wide CIs; however, 13 (42%) eyes randomized to hydrophobic versus two (8%) eyes randomized to hydrophilic acrylic IOLs developed 1+ or greater giant cell deposits on IOL (RR 6.50, 95% 1.60 to 26.36). </p> <p>Quality of life outcomes were not reported in any study.</p> </section> <section id="CD007284-sec-0119"> <h3 class="title" id="CD007284-sec-0119">Overall completeness and applicability of evidence</h3> <p>Overall, the four studies specified different outcome measures, evaluated different IOLs, and were not consistent in elaborating the types or etiologies of uveitis. For example, the etiologies of uveitis in participants from the largest study were not reported (<a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>). <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> specified that participants had "noninfectious" uveitis and listed the etiologies, such as "juvenile idiopathic arthritis, adult". Juvenile idiopathic arthritis may overlap with juvenile rheumatoid arthritis, one of the two types of uveitis that was excluded from <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>. <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> specified Behçet disease, Vogt‐Koyanagi‐Harada, and "non‐granulomatous" uveitis. Although <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> argued that "accurate patient selection fulfilling the inclusion and exclusion criteria, along with the preoperative and postoperative control of ocular inflammation and a standardized surgical procedure, nullified etiology as a variable that might affect the clinical results" and they "accordingly...found no need to group cases according to etiology", etiology would be important to include as uveitis has ethnic/geographic predilections. Even without the inclusion of two types of uveitis in <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>, there exists a wide range of types of uveitic disease, whose natural course could alter the results of cataract extraction with IOL. One study did not exclude children (<a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a>), and the risks of cataract surgery with IOL implantation for children are different from adults undergoing surgery, including increased inflammatory response, secondary glaucoma, secondary membrane formation, and inadequate IOL power choice in a growing eye (<a href="./references#CD007284-bbs2-0028" title="DharmarajS , AzarN . Controversies of implanting intraocular lenses in infancy. International Ophthalmology Clinics2005;45(4):61‐81. ">Dharmaraj 2005</a>; <a href="./references#CD007284-bbs2-0034" title="HilesDA , WatsonBA . Complications of implant surgery in children. Journal ‐ American Intra‐Ocular Implant Society Journal1979;5(1):24‐32. ">Hiles 1979</a>; <a href="./references#CD007284-bbs2-0044" title="TrivediRH , WilsonMEJr , GolubRL . Incidence and risk factors for glaucoma after pediatric cataract surgery with and without intraocular lens implantation. Journal of AAPOS2006;10(2):117‐23. ">Trivedi 2006</a>). </p> <p>The rate of CME, an important outcome measure for cataract surgery, was mentioned in two studies (<a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>; <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a>). Development of PCO in addition to the rate of Nd:YAG capsulotomy are other important outcomes that may reflect what Roesel termed, "capsular biocompatibility". However, PCO development may also be a result of IOL design (sharp‐edged optic versus other) and not reflective of material biocompatibility. "Relapse" (<a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>) or "reactivation" (<a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a>) of inflammation is another outcome measure for which the investigators of both studies used laser flare photometry, which was not included in the <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> or <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a> studies. There was no mention of recurrence or relapse in <a href="./references#CD007284-bbs2-0002" title="MesterU , StraussM , GrewingR . Biocompatibility and blood‐aqueous barrier impairment in at‐risk eyes with heparin‐surface‐modified or unmodified lenses. Journal of Cataract and Refractive Surgery1998;24(3):380‐4. ">Mester 1998</a> and <a href="./references#CD007284-bbs2-0004" title="TabbaraKF , Al‐KaffAS , Al‐RajhiAA , Al‐MansouriSM , BadrIA , ChavisPS , et al. Heparin surface‐modified intraocular lenses in patients with inactive uveitis or diabetes. Ophthalmology1998;105(5):843‐5. ">Tabbara 1998</a>, though the investigators may have chosen to use posterior synechiae and IOL cellular deposits as surrogate outcomes for inflammation. <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> and <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> reported development of CME and relapse/reactivation of inflammation, and measured "giant cell" deposition on the IOL surface, which is not a standard outcome measure. </p> <p>The publication dates of the four trials included in this review ranged from 1998 through 2008. Changes in materials and technology have evolved beyond the use of certain types of IOLs since then. For example, PMMA IOLs, which are rigid IOLs, have become superseded by flexible materials, such as acrylic, silicone, and hydrogel (<a href="./references#CD007284-bbs2-0013" title="JancevskiM , FosterCS . Cataracts and uveitis. Current Opinion in Ophthalmology2010;21(1):10‐4. JancevskiM , FosterCS . Cataracts and uveitis. Discovery Medicine2010;9(44):51‐4. ">Jancevski 2010</a>). </p> </section> <section id="CD007284-sec-0120"> <h3 class="title" id="CD007284-sec-0120">Quality of the evidence</h3> <p>The studies included in this review were heterogeneous with respect to the types of IOLs evaluated (e.g. material of lenses, modification to surface of lenses), the underlying uveitic condition among study participants, the study methods and risks of bias, and the outcomes measured and reported. The number of participants included in the studies ranged from 2 to 140 (total of 216 participants); none of the studies reported sample size calculations needed to detect differences between treatment groups. The largest study in this review was a multicenter study in which not all study centers had access to all the types of lens implants, leading to varying numbers of participants in the four treatment groups (<a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>). The number of participants in the two types of PMMA groups was smaller compared with the hydrophobic acrylic and silicone IOL groups; it is unclear whether the study was powered to detect differences among these lenses. Further, outcome assessors in all four studies were not masked (although two studies measured only objective outcomes), uveitis type was not consistently provided, and outcome measures, types of lens material, follow‐up periods, and patient populations were different across the studies, risking external validity for any one or all four studies. </p> </section> <section id="CD007284-sec-0121"> <h3 class="title" id="CD007284-sec-0121">Potential biases in the review process</h3> <p>In order to minimize potential selection bias in the review process, we devised a highly sensitive search strategy and reviewed records in duplicate by at least one clinician and one methodologist. Further, we abstracted data in duplicate and contacted study investigators when data were missing. However, we did not receive replies for all queries and some data are reported based on information as available. Due to the heterogeneity among studies and the lack of study protocols available, we could not assess potential selective outcome reporting or publication bias. </p> <p>Although we feel that the systematic search for trials was comprehensive and selection bias was minimized, we identified only four trials with 216 total participants. This small number of study participants presents limitations to the interpretation of treatment effects including insufficient power to detect differences between treatment groups and unreliability in identifying adverse events. </p> </section> <section id="CD007284-sec-0122"> <h3 class="title" id="CD007284-sec-0122">Agreements and disagreements with other studies or reviews</h3> <p>There is a limited number of reviews regarding the optimal IOL to use in uveitic cataract surgery. However, the consensus of recent studies regarding cataract surgery in people with uveitis is that implantation of IOLs may be safely performed when ocular inflammation is well controlled. The <a href="./references#CD007284-bbs2-0018" title="PerryLJ , PapaliodisGN . Selection of intraocular lenses in patients with uveitis. International Ophthalmology Clinics2010;50(1):61‐70. ">Perry 2010</a> review concluded that acrylic and HSM PMMA lenses perform better in uveitic eyes than other lens types. This concurs with the conclusion from the <a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a> trial that an acrylic IOL is preferable over a silicone IOL. However, in the four studies identified by this review, we found insufficient evidence to support of HSM lenses over other unmodified lenses. </p> <p>Regarding hydrophilic and hydrophobic acrylic IOLs, the largest RCT study in this review did not compare hydrophobic acrylic IOLs with hydrophilic acrylic IOLs (<a href="./references#CD007284-bbs2-0001" title="AlióJL , ChipontE , BenEzraD , FakhryMA , International Ocular Inflammation Society, Study Group of Uveitic Cataract Surgery. Comparative performance of intraocular lenses in eyes with cataract and uveitis. Journal of Cataract and Refractive Surgery2002;28(12):2096‐108. AlióJL , ChipontEM , FakhryMA , EzraDB . Comparative performance of intraocular lenses in uveitic eyes with cataract. American Academy of Ophthalmology2000:113. BurtinT . Comparison of heparin surface‐modified and soft acrylic hydrophobic intraocular lenses in chronic uveitis. American Academy of Ophthalmology1999:178. ChipontE , AlióJL , SmithAF , FakhryMA , GarciaP . Comparative performance of four types of intraocular lenses in the uveitic eye: health economic analysis. American Academy of Ophthalmology2002:240. PapaliodisGN , NguyenQD , SamsonCM , FosterCS . Intraocular lens tolerance in surgery for cataracta complicata: assessment of four implant materials. Seminars in Ophthalmology2002;17(3‐4):120‐3. ">Alió 2002</a>), and <a href="./references#CD007284-bbs2-0003" title="HeinzC , RoeselM , HeiligenhausA . Uveal and capsular biocompatibility of two acrylic intraocular lenses in patients with non‐infectious uveitis. Investigative Ophthalmology and Visual Science2007;48:ARVO E‐Abstract 3915. RoeselM , HeinzC , HeimesB , KochJM , HeiligenhausA . Uveal and capsular biocompatibility of two foldable acrylic intraocular lenses in patients with endogenous uveitis ‐ a prospective randomized study. Graefe's Archive for Clinical and Experimental Ophthalmology2008;246(11):1609‐15. RoeselM , HeinzC , KochJM , HeiligenhausA . Cataract surgery in uveitis. Ophthalmology2008; Vol. 115, issue 8:1431. ">Roesel 2008</a> did not find any statistically significant differences at six months between hydrophobic and hydrophilic acrylic IOLs. However, a comparative case series by <a href="./references#CD007284-bbs2-0005" title="Abela‐FormanekC , AmonM , SchauersbergerJ , KrugerA , NeppJ , SchildG . Results of hydrophilic acrylic, hydrophobic acrylic, and silicone intraocular lenses in uveitic eyes with cataract: comparison to a control group. Journal of Cataract and Refractive Surgery2002;28(7):1141‐52. Abela‐FormanekC , AmonM , SchauersbergerJ , SchildG , KolodjaschnaJ , Barisani‐AsenbauerT , et al. Uveal and capsular biocompatibility of 2 foldable acrylic intraocular lenses in patients with uveitis or pseudoexfoliation syndrome: comparison to a control group. Journal of Cataract and Refractive Surgery2002;28(7):1160‐72. Abela‐FormanekC , AmonM , SchildG , SchauersbergerJ , KolodjaschnaJ , Barisani‐AsenbaumT , et al. Inflammation after implantation of hydrophilic acrylic, hydrophobic acrylic, or silicone intraocular lenses in eyes with cataract and uveitis: comparison to a control group. Journal of Cataract and Refractive Surgery2002;28(7):1153‐9. ">Abela‐Formanek 2002</a> concluded that while all sharp‐edged hydrophilic and hydrophobic IOLs performed well in uveitic eyes, acrylic hydrophilic IOLs achieved higher uveal biocompatibility compared with the acrylic hydrophobic IOLs. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007284-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/media/CDSR/CD007284/urn:x-wiley:14651858:media:CD007284:CD007284-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/media/CDSR/CD007284/image_t/tCD007284-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD007284-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007284.pub2/media/CDSR/CD007284/image_n/nCD007284-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full#CD007284-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/media/CDSR/CD007284/image_n/nCD007284-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007284-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/media/CDSR/CD007284/urn:x-wiley:14651858:media:CD007284:CD007284-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/media/CDSR/CD007284/image_t/tCD007284-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgments about each risk of bias item for each included study." data-id="CD007284-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007284.pub2/media/CDSR/CD007284/image_n/nCD007284-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgments about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full#CD007284-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/media/CDSR/CD007284/image_n/nCD007284-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD007284-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Visual acuity outcomes at one year by intraocular lens types in Alió 2002 study</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Type of IOLs compared</b> </p> <p><b>(number of participants)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="4" rowspan="1" valign=""> <p><b>BCVA, measured as Snellen equivalent</b> </p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>≥ 1 lines gained<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>≥ 20/40<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>≤ 20/200<br/> RR (95% CI)**</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean BCVA<br/> (Mean ± number of lines)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06 (0.93 to 1.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.06 (1.20 to 3.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57 (0.20 to 1.62)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/80 ± 2) versus (20/160 ± 1) (P value = 0.006)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus unmodified PMMA (26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.11 (0.93 to 1.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.13 (0.71 to 1.78)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.68 (0.20 to 2.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/80 ± 2) versus (20/100 ± 2) (P value ≥ 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus HSM PMMA (22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.15 (0.93 to 1.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.13 (0.69 to 1.83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 (0.15 to 1.42)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/80 ± 2) versus (20/120 ± 2) (P value ≥ 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unmodified (26) PMMA versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 (0.79 to 1.16)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83 (0.99 to 3.40)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85 (0.28 to 2.54)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/100 ± 2) versus (20/160 ± 1) (P value = 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HSM PMMA (22) versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92 (0.74 to 1.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83 (0.97 to 3.47)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25 (0.46 to 3.38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/120 ± 2) versus (20/160 ± 1) (P value ≥ 0.05)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unmodified (26) PMMA versus HSM PMMA (22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03 (0.80 to 1.34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00 (0.57 to 1.76)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.68 (0.21 to 2.22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>(20/100 ± 2) versus (20/120 ± 2) (P value ≥ 0.05)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="5"> <div class="table-footnote"> <p>BCVA: best‐corrected visual acuity; CI: confidence interval; HSM: heparin‐surface modified; IOL: intraocular lens; PMMA: poly(methyl methacrylate); RR: risk ratio. </p> <p>*RRs &gt; 1 favor the test IOL type and RRs &lt; 1 favor the comparison IOL type.<br/> **RRs &lt; 1 favor the test IOL type and RRs &gt; 1 favor the comparison IOL type. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Visual acuity outcomes at one year by intraocular lens types in Alió 2002 study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full#CD007284-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007284-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Adverse outcomes at one year by intraocular lens types in Alió 2002 study</span></div> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Type of IOLs compared</b> </p> <p><b>(number of participants)</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Additional<br/> interventions<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>PCO<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Posterior<br/> synechiae<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Postoperative<br/> inflammation<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Corneal edema<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>CME<br/> RR (95% CI)*</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mild IOL<br/> decentration<br/> RR (95% CI)*</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61 (0.11 to 3.49)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74 (0.41 to 1.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.18 (0.04 to 0.79)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.72 (0.49 to 1.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.49 (0.22 to 1.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.10 (0.01 to 1.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92 (0.06 to 14.22)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus unmodified PMMA (26)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.76 (0.14 to 55.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78 (0.39 to 1.58)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.76 (0.14 to 55.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.74 (0.48 to 1.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.79 (0.49 to 29.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.18 (0.01 to 4.36)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.65 (0.07 to 39.20)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Acrylic (48) versus HSM PMMA (22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.35 (0.12 to 46.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60 (0.31 to 1.14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 (0.07 to 3.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.26 (0.67 to 2.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.07 (0.30 to 3.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in both groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.41 (0.06 to 33.26)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unmodified (26) PMMA versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.24 (0.01 to 4.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.95 (0.49 to 1.84)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.08 (0.00 to 1.30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.97 (0.66 to 1.41)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.13 (0.02 to 0.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.42 (0.05 to 3.59)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.56 (0.02 to 13.16)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HSM PMMA (22) versus silicone (44)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.28 (0.02 to 5.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25 (0.68 to 2.28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.40 (0.10 to 1.67)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57 (0.31 to 1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46 (0.15 to 1.45)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22 (0.01 to 3.87)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.65 (0.03 to 15.39)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unmodified (26) PMMA versus HSM PMMA (22)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in both groups</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.76 (0.38 to 1.53)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17 (0.01 to 3.37)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.69 (0.90 to 3.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.28 (0.03 to 2.52)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.56 (0.11 to 59.75)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0 in both groups</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>CI: confidence interval; CME: cystoid macular edema; HSM: heparin‐surface modified; IOL: intraocular lens; PCO: posterior capsule opacification; PMMA: poly(methyl methacrylate); RR: risk ratio.<br/> <br/> *RRs &lt; 1 favor the test IOL type and RRs &gt; 1 favor the comparison IOL type. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Adverse outcomes at one year by intraocular lens types in Alió 2002 study</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007284.pub2/full#CD007284-tbl-0002">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007284.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007284-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007284-note-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007284-note-0003">Français</a> </li> <li class="section-language"> <a class="" href="ko#CD007284-note-0002">한국어</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD007284-note-0001">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007284\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007284\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007284\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007284\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007284\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Nio3SV1W&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007284.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007284.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007284.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007284.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007284.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729244933"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007284.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"/> <span class="taglib-text hide-accessible">Sign In</span> </span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729244937"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007284.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ed82ef840f55b',t:'MTc0MDcyOTI0NS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 